Stockreport

AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) [Yahoo! Finance]

AN2 Therapeutics, Inc.  (ANTX) 
US:NYSE Investor Relations: ir.antheminc.com
PDF AN2 to host webcast on Wednesday, March 4, 2026 at 9:30am ET/ 6:30am PT MENLO PARK, Calif., March 03, 2026 BUSINESS WIRE )--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a c [Read more]